Sold at 1.11 Not happy to have done so but I fear that this mess with Glaucus is going to get worse before it gets better. Cheers, Tim.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025